Ditchcarbon
  • Customers
  1. Organizations
  2. Msn Laboratories
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 11 days ago

Msn Laboratories

Company website

Msn Laboratories, officially known as Msn Laboratories Pvt. Ltd., is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has rapidly expanded its operations across major regions, including Europe, the Americas, and Asia, solidifying its position in the global market. Specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, Msn Laboratories is recognised for its commitment to quality and innovation. The company’s core products include a diverse range of therapeutic solutions, particularly in the fields of oncology, cardiology, and anti-infectives, setting it apart with its robust research and development capabilities. With a strong market presence, Msn Laboratories has achieved several milestones, including regulatory approvals from major health authorities, which underscores its dedication to excellence and reliability in the pharmaceutical sector.

DitchCarbon Score

How does Msn Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

24

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Msn Laboratories's score of 24 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Msn Laboratories's reported carbon emissions

In 2024, Msn Laboratories reported total carbon emissions of approximately 126,073,600 kg CO2e for Scope 1 and about 135,767,630 kg CO2e for Scope 2. Additionally, their Scope 3 emissions were approximately 66,735,710 kg CO2e, which included significant contributions from purchased goods and services (about 12,726,040 kg CO2e) and fuel and energy-related activities (approximately 42,445,000 kg CO2e). Comparatively, in 2023, Msn Laboratories' emissions were approximately 83,016,740 kg CO2e for Scope 1 and about 109,040,650 kg CO2e for Scope 2, indicating a substantial increase in emissions in 2024. The company has not disclosed Scope 3 emissions data for 2023. Msn Laboratories is committed to achieving net zero emissions by 2045, a goal that underpins their strategic initiatives and operational improvements. This long-term commitment encompasses all scopes of emissions, reflecting a comprehensive approach to climate action. The emissions data is not cascaded from any parent organization, indicating that Msn Laboratories is independently reporting its emissions and climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
83,016,740
00,000,000
000,000,000
Scope 2
109,040,650
000,000,000
000,000,000
Scope 3
-
-
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Msn Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Msn Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Msn Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alembic Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Hetero Drugs

IN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Biocon

IN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bdr Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Nosch Labs Private Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Enaltec Labs

IN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy